UPDATE
: Monday, September 7, 2020
Home
Login
Mobile Version
All
Hospital
Pharma
Bio
Korea‘s Bio Industry
Device/ICT
Policy
People
Life science
Special
Innovation for Survival
Korea’s medical culture series
Korea’s New Candidate Drug Watch List
Special Series in Celebration of KBR's 1st Anniversary
Interview with foreign envoys
Special Series in Celebration of KBR’s 2nd Anniversary
Interview with global pharma
Special Series in Celebration of KBR’s 3rd Anniversary
Special Series in Celebration of KBR’s 4th Anniversary
ASCO 2020 Highlights
Opinion
Reporter’s Notebook
Search
트위터
페이스북
RSS
상단여백
기사
(전체 3,444건)
제목보기
제목보기
제목+내용
기사보기
Sillajen’s trouble heralds fall of one of most prominent biotech firms
Shares of Sillajen conti...
Lee Han-soo
|
2019-08-05 16:55
기사보기
Boycott of Japanese drug intensifies as Seoul-Tokyo relations worsen
With Japan deciding to r...
Lee Han-soo
|
2019-08-05 16:01
기사보기
Amgen’s lipid-lowering Repatha beats Sanofi’s Praluent in Q2 sales
Amgen won the battle aga...
Kim Yun-mi
|
2019-08-05 15:37
기사보기
SillaJen remains confident about Pexa-Vec’s value, despite trial failure
SillaJen said Pexa-Vec, ...
Jeong Sae-im
|
2019-08-05 14:49
기사보기
Suspicions resurge over SillaJen execs’ stock selling before Pexa-Vec trial suspension
Jeong Sae-im
|
2019-08-05 11:26
기사보기
Helixmith unveils results for neuromuscular disease treatment
Helixmith has published ...
Lee Han-soo
|
2019-08-02 17:52
기사보기
Japan’s 'whitelist’ removal to have minimal effect on biopharmaceutical sector
Lee Han-soo
|
2019-08-02 17:14
기사보기
‘MSD Korea playing tricks to maintain monitoring on salespersons’
MSD Korea’s labor and ma...
Kim Yun-mi
|
2019-08-02 15:48
기사보기
Biotech shares tank amid SillaJen’s likely halt of Pexa-Vec trial
Local biotech shares wen...
Jeong Sae-im
|
2019-08-02 15:45
기사보기
Conflict erupts between employees of Takeda, Shire during merger
Takeda Pharmaceutical Ko...
Kim Yun-mi
|
2019-08-02 14:23
기사보기
Researchers use ultrasonic wave to charge in-body medical devices
A local research team ha...
Lee Han-soo
|
2019-08-02 14:09
기사보기
Sillajen likely to scrap global P3 trials for Pexa-Vec
Sillajen is in danger of...
Lee Han-soo
|
2019-08-02 10:29
-
이전
171
172
173
174
175
176
177
178
179
180
다음
-
Back to Top